San Francisco Biotech →
President & CEO, Indiana Biosciences Research Institute
Managing Director, D.E. Shaw and Co., L.P.
Founder, Gilt Groupe
Founder and Chairman, Sycamore Networks
Managing director, the Foundry Group
Professor of Systems Biology, Columbia University
Founder and Managing Director of DEV
Founder and Managing Partner, Frazier Healthcare Ventures
December 5, 2018 · San Francisco
December 18, 2018 · New York
May 29, 2019 · San Diego
As 2011 nears its midpoint, we’re now in a position to see how the recession-era and follow-on consolidation trends have impacted middle-market and growth-stage mergers and acquisitions.
Large blue-chip technology companies,... Read more »
[Editor’s note: This post was co-authored by Moss Adams partners Ken Salgado (based in Southern California) and Derek Dowsett (Silicon Valley).]
It’s early in the year, and although there... Read more »
At the end of 2009, we were optimistic that the M&A markets would pick up and become the key near-term source of liquidity for investors before any real momentum in the... Read more »
It’s obvious that the financial downturn has negatively impacted innovation. Lack of investment has meant fewer startups, and lack of capital for liquidity events and exits has pushed a listless market... Read more »
The second half of 2009 provided a good measure of optimism, easing some of the pain investors felt toward the end of 2008 and in early 2009. The stock market has... Read more »
Xconomy Insight · Special Report
Get advice from the experts to help your biotech startup succeed
Xconomy offers a number of ways to subscribe for free!
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit/Ann Arbor, San Francisco, New York, Raleigh-Durham, Boulder/Denver, Texas, Wisconsin, Indiana, and beyond.
© 2007-2018, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Website development support from Andrew Koyfman with design support from Rob Hunter.